These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19088696)

  • 21. Management of medullary thyroid carcinoma.
    Jiménez C; Hu MI; Gagel RF
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary thyroid carcinoma and biomarkers: past, present and future.
    van Veelen W; de Groot JW; Acton DS; Hofstra RM; Höppener JW; Links TP; Lips CJ
    J Intern Med; 2009 Jul; 266(1):126-40. PubMed ID: 19522831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medullary thyroid cancer: early detection and novel treatments.
    Roman S; Mehta P; Sosa JA
    Curr Opin Oncol; 2009 Jan; 21(1):5-10. PubMed ID: 19125012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Targeted radionuclide therapy for patients with metastatic medullary thyroid carcinoma].
    Gao ZR; An R; Zhang YX; Biersack HJ
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):621-4. PubMed ID: 17236560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy.
    Samaan NA; Schultz PN; Hickey RC
    Horm Metab Res Suppl; 1989; 21():21-5. PubMed ID: 2807151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report.
    Unruh A; Fitze G; Jänig U; Bielack S; Lochbühler H; Coerdt W
    J Pediatr Surg; 2007 Sep; 42(9):1623-6. PubMed ID: 17848262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma.
    Santarpia L; Ye L; Gagel RF
    J Intern Med; 2009 Jul; 266(1):99-113. PubMed ID: 19522829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B.
    Shimotake T; Tsuda T; Aoi S; Fumino S; Iwai N
    J Pediatr Surg; 2005 Oct; 40(10):1643-6. PubMed ID: 16226999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation of a medullary endocrine neoplasia 2A kindred with Cushing's syndrome.
    Zaydfudim V; Stover DG; Caro SW; Phay JE
    Am Surg; 2008 Jul; 74(7):659-61. PubMed ID: 18646485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy.
    Gao Z; Biersack HJ; Ezziddin S; Logvinski T; An R
    J Cancer Res Clin Oncol; 2004 Nov; 130(11):649-56. PubMed ID: 15300425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Useful and limits of the biochemical markers for the diagnosis of thyroid carcinoma].
    Colombo P; Locatelli F; Travaglini P
    Ann Ital Chir; 2006; 77(3):209-14. PubMed ID: 17137035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms.
    Pasieka JL; McEwan AJ; Rorstad O
    Surgery; 2004 Dec; 136(6):1218-26. PubMed ID: 15657579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
    Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
    Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
    Erdogan MF; Gursoy A
    Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer.
    Santarpia L; Gagel RF; Sherman SI; Sarlis NJ; Evans DB; Hoff AO
    Head Neck; 2009 Mar; 31(3):419-23. PubMed ID: 18798312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
    Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
    Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.
    Chatal JF; Campion L; Kraeber-Bodéré F; Bardet S; Vuillez JP; Charbonnel B; Rohmer V; Chang CH; Sharkey RM; Goldenberg DM; Barbet J;
    J Clin Oncol; 2006 Apr; 24(11):1705-11. PubMed ID: 16549819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodine-131 MIBG imaging in multiple endocrine neoplasia type 2B.
    Yamamoto Y; Isobe Y; Nishiyama Y; Takashima H; Ohkawa M; Kihara M; Matsusaka K; Miyauchi A; Kobayashi S; Tanabe M
    Clin Nucl Med; 1998 Jan; 23(1):13-5. PubMed ID: 9442958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.